{"id":18281,"date":"2025-07-24T12:54:50","date_gmt":"2025-07-24T12:54:50","guid":{"rendered":"https:\/\/itbusinesstoday.com\/?p=18281"},"modified":"2025-07-24T12:54:50","modified_gmt":"2025-07-24T12:54:50","slug":"curadh-alpha-fusion-advance-astatine-211-collaboration","status":"publish","type":"post","link":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/curadh-alpha-fusion-advance-astatine-211-collaboration\/","title":{"rendered":"\u30ad\u30e5\u30e9\u30fc\u30ba\u3068\u30a2\u30eb\u30d5\u30a1\u30fb\u30d5\u30e5\u30fc\u30b8\u30e7\u30f3\u793e\u3001\u30a2\u30b9\u30bf\u30c1\u30f3-211\u306e\u5171\u540c\u7814\u7a76\u3092\u63a8\u9032"},"content":{"rendered":"<?xml encoding=\"utf-8\" ?><p>\u30ad\u30e5\u30e9\u30fc\u30baMTR\u793e\u3068\u30a2\u30eb\u30d5\u30a1\u30fb\u30d5\u30e5\u30fc\u30b8\u30e7\u30f3\u793e\u306f\u3001\u4eca\u6708\u672b\u306b\u30b5\u30f3\u30c7\u30a3\u30a8\u30b4\u3067\u958b\u50ac\u3055\u308c\u308b\u7b2c4\u56de\u30bf\u30fc\u30b2\u30c3\u30c8\u653e\u5c04\u6027\u533b\u85ac\u54c1\u30b5\u30df\u30c3\u30c8US\u306b\u304a\u3044\u3066\u3001\u653e\u5c04\u6027\u533b\u85ac\u54c1\u958b\u767a\u306e\u9032\u6357\u72b6\u6cc1\u3092\u767a\u8868\u3059\u308b\u4e88\u5b9a\u3067\u3059\u3002\u4e21\u793e\u306f\u6700\u8fd1\u3001\u30a2\u30b9\u30bf\u30c1\u30f3211\uff08At-211\uff09\u30d9\u30fc\u30b9\u306e\u653e\u5c04\u6027\u533b\u85ac\u54c1\u3092\u69d8\u3005\u306a\u764c\u306e\u6cbb\u7642\u306b\u4f7f\u7528\u3059\u308b\u305f\u3081\u306e\u4e16\u754c\u7684\u306a\u9032\u6b69\u3092\u63a8\u9032\u3059\u308b\u5408\u5f01\u4f1a\u793e\u306e\u8a2d\u7acb\u3092\u542b\u3080\u6226\u7565\u7684\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u3092\u7de0\u7d50\u3059\u308b\u8a08\u753b\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002.<\/p><p>Curadh MTR\u306e\u30c1\u30fc\u30d5\u30fb\u30e1\u30c7\u30a3\u30ab\u30eb\u30fb\u30aa\u30d5\u30a3\u30b5\u30fc\u517c\u5275\u8a2d\u8005\u3067\u3042\u308b\u30a2\u30ea\u30bd\u30f3\u30fb\u30a2\u30fc\u30e2\u30a2\u535a\u58eb\u304c\u3001\u4ee5\u4e0b\u306e\u30bf\u30a4\u30c8\u30eb\u306e\u30bb\u30df\u30ca\u30fc\u3092\u958b\u50ac\u3057\u307e\u3059\u3002 <em>\u653e\u5c04\u6027\u533b\u85ac\u54c1\u958b\u767a\u306b\u304a\u3051\u308b\u60a3\u8005\u306e\u5b89\u5168\u6027\u3092\u78ba\u4fdd\u3059\u308b\u305f\u3081\u306e\u81e8\u5e8a\u30c7\u30b6\u30a4\u30f3\u306e\u6700\u9069\u5316<\/em>. Reflecting on her recent presentation at the World Astatine Community Meeting, she noted, &ldquo;Astatine&rsquo;s short 7.2-hour half-life provides significant advantages over other radioisotopes, notably reducing radiation exposure for patients, caregivers, and healthcare personnel.&rdquo;<\/p><p>Commenting on the collaboration, Glenn Kazo, CEO of Curadh, said, &ldquo;Alpha Fusion is currently the only company worldwide with multiple At-211-based therapies in clinical trials. We&rsquo;re eager to deepen our partnership, building on the impressive work led by Dr. Watabe and the Alpha Fusion team in Japan.&rdquo;<\/p><h4>\u3053\u3061\u3089\u3082\u304a\u8aad\u307f\u304f\u3060\u3055\u3044\uff1a <a class=\"p-url\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/cosmos-taps-relex-to-optimize-supply-chain-and-growth\/\" rel=\"bookmark\">\u30b3\u30b9\u30e2\u30b9\u3001\u30b5\u30d7\u30e9\u30a4\u30c1\u30a7\u30fc\u30f3\u306e\u6700\u9069\u5316\u3068\u6210\u9577\u306e\u305f\u3081\u306bRELEX\u3092\u63a1\u7528<\/a><\/h4><p>Dr. Tadashi Watabe of the University of Osaka&rsquo;s Graduate School of Medicine recently shared promising Phase I clinical trial results at the SNMMI. The trial led by investigators showed that At-211 is both tolerable and effective for patients with thyroid cancer who resist radioiodine therapy.<\/p><p>&ldquo;At-211 is moving forward fast in clinical development, so we&rsquo;re excited to grow in U.S. and global markets,&rdquo; said Sunao Fujioka, CEO of <a href=\"https:\/\/alpha-fusion.com\/\" data-no-translation=\"\">Alpha Fusion<\/a>. &ldquo;Our partnership with <a href=\"https:\/\/curadhmtr.com\/\" data-no-translation=\"\">Curadh<\/a>, combining their deep radiopharmaceutical expertise with Alpha Fusion&rsquo;s platform, is instrumental in driving this growth.&rdquo;<\/p>","protected":false},"excerpt":{"rendered":"<p>Curadh MTR Inc. and Alpha Fusion, Inc. are set to showcase their progress in radiopharmaceutical development at the 4th Targeted Radiopharmaceuticals Summit US, scheduled later this month in San Diego. The two companies recently announced plans to enter a strategic partnership, which includes forming a joint venture to drive the global advancement of Astatine-211 (At-211)-based radiopharmaceuticals for the treatment of various cancers.Dr. Alison Armour, Chief Medical Officer and Founder of Curadh MTR, will lead a seminar titled Optimizing Clinical Design to Ensure Patient Safety in Radiopharmaceutical Development. Reflecting on her recent presentation at the World Astatine Community Meeting, she noted, &ldquo;Astatine&rsquo;s short 7.2-hour half-life provides significant advantages over other radioisotopes, [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":18282,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"wprm-recipe-roundup-name":"","wprm-recipe-roundup-description":"","postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"footnotes":""},"categories":[89,207,237,182],"tags":[5815,6525,6526,424,5812],"ppma_author":[572],"class_list":["post-18281","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health-tech","category-international","category-news","category-pharma","tag-alpha-fusion","tag-astatine-211","tag-curadh","tag-pharma","tag-radiopharmaceuticals"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Curadh, Alpha Fusion Expand Astatine-211 Drug Partnership<\/title>\n<meta name=\"description\" content=\"Curadh and Alpha Fusion will present on Astatine-211 radiopharmaceuticals at the Targeted Radiopharmaceuticals Summit for global R&amp;D.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/curadh-alpha-fusion-advance-astatine-211-collaboration\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Curadh, Alpha Fusion Expand Astatine-211 Drug Partnership\" \/>\n<meta property=\"og:description\" content=\"Curadh and Alpha Fusion will present on Astatine-211 radiopharmaceuticals at the Targeted Radiopharmaceuticals Summit for global R&amp;D.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/curadh-alpha-fusion-advance-astatine-211-collaboration\/\" \/>\n<meta property=\"og:site_name\" content=\"itbusinesstoday\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-24T12:54:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/07\/Curadh-and-Alpha-Fusion-Advance-Astatine-211-Radiopharmaceuticals-Partnership.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"ITBT StaffWriter\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"ITBT StaffWriter\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30ad\u30e5\u30e9\u30fc\u30ba\u3068\u30a2\u30eb\u30d5\u30a1\u30fb\u30d5\u30e5\u30fc\u30b8\u30e7\u30f3\u793e\u3001\u30a2\u30b9\u30bf\u30c1\u30f3211\u306e\u63d0\u643a\u3092\u62e1\u5927","description":"\u30ad\u30e5\u30e9\u30fc\u30ba\u3068\u30a2\u30eb\u30d5\u30a1\u30fb\u30d5\u30e5\u30fc\u30b8\u30e7\u30f3\u306f\u3001\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u7814\u7a76\u958b\u767a\u5411\u3051\u306e\u30bf\u30fc\u30b2\u30c3\u30c8\u653e\u5c04\u6027\u533b\u85ac\u54c1\u30b5\u30df\u30c3\u30c8\u3067\u3001\u30a2\u30b9\u30bf\u30c1\u30f3211\u653e\u5c04\u6027\u533b\u85ac\u54c1\u306b\u3064\u3044\u3066\u767a\u8868\u3057\u307e\u3059\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/curadh-alpha-fusion-advance-astatine-211-collaboration\/","og_locale":"ja_JP","og_type":"article","og_title":"Curadh, Alpha Fusion Expand Astatine-211 Drug Partnership","og_description":"Curadh and Alpha Fusion will present on Astatine-211 radiopharmaceuticals at the Targeted Radiopharmaceuticals Summit for global R&D.","og_url":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/curadh-alpha-fusion-advance-astatine-211-collaboration\/","og_site_name":"itbusinesstoday","article_published_time":"2025-07-24T12:54:50+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/07\/Curadh-and-Alpha-Fusion-Advance-Astatine-211-Radiopharmaceuticals-Partnership.webp","type":"image\/webp"}],"author":"ITBT StaffWriter","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"ITBT StaffWriter","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/curadh-alpha-fusion-advance-astatine-211-collaboration\/#article","isPartOf":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/curadh-alpha-fusion-advance-astatine-211-collaboration\/"},"author":{"name":"ITBT StaffWriter","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15"},"headline":"Curadh, Alpha Fusion Advance Astatine-211 Collaboration","datePublished":"2025-07-24T12:54:50+00:00","mainEntityOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/curadh-alpha-fusion-advance-astatine-211-collaboration\/"},"wordCount":282,"publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/curadh-alpha-fusion-advance-astatine-211-collaboration\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/07\/Curadh-and-Alpha-Fusion-Advance-Astatine-211-Radiopharmaceuticals-Partnership.webp","keywords":["Alpha Fusion","Astatine-211","Curadh","Pharma","radiopharmaceuticals"],"articleSection":["Health Tech","International","News","Pharma"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/curadh-alpha-fusion-advance-astatine-211-collaboration\/","url":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/curadh-alpha-fusion-advance-astatine-211-collaboration\/","name":"\u30ad\u30e5\u30e9\u30fc\u30ba\u3068\u30a2\u30eb\u30d5\u30a1\u30fb\u30d5\u30e5\u30fc\u30b8\u30e7\u30f3\u793e\u3001\u30a2\u30b9\u30bf\u30c1\u30f3211\u306e\u63d0\u643a\u3092\u62e1\u5927","isPartOf":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website"},"primaryImageOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/curadh-alpha-fusion-advance-astatine-211-collaboration\/#primaryimage"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/curadh-alpha-fusion-advance-astatine-211-collaboration\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/07\/Curadh-and-Alpha-Fusion-Advance-Astatine-211-Radiopharmaceuticals-Partnership.webp","datePublished":"2025-07-24T12:54:50+00:00","description":"Curadh\u3068\u30a2\u30eb\u30d5\u30a1\u30fb\u30d5\u30e5\u30fc\u30b8\u30e7\u30f3\u306f\u3001\u30b0\u30ed\u30fc\u30d0\u30ebR&amp;D\u5411\u3051\u30bf\u30fc\u30b2\u30c3\u30c8\u653e\u5c04\u6027\u533b\u85ac\u54c1\u30b5\u30df\u30c3\u30c8\u3067\u3001\u30a2\u30b9\u30bf\u30c1\u30f3211\u653e\u5c04\u6027\u533b\u85ac\u54c1\u306b\u3064\u3044\u3066\u767a\u8868\u3057\u307e\u3059\u3002.","breadcrumb":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/curadh-alpha-fusion-advance-astatine-211-collaboration\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/itbusinesstoday.com\/health-tech\/pharma\/curadh-alpha-fusion-advance-astatine-211-collaboration\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/curadh-alpha-fusion-advance-astatine-211-collaboration\/#primaryimage","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/07\/Curadh-and-Alpha-Fusion-Advance-Astatine-211-Radiopharmaceuticals-Partnership.webp","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/07\/Curadh-and-Alpha-Fusion-Advance-Astatine-211-Radiopharmaceuticals-Partnership.webp","width":1200,"height":800,"caption":"Curadh"},{"@type":"BreadcrumbList","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/curadh-alpha-fusion-advance-astatine-211-collaboration\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/itbusinesstoday.com\/"},{"@type":"ListItem","position":2,"name":"Curadh, Alpha Fusion Advance Astatine-211 Collaboration"}]},{"@type":"WebSite","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","description":"","publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","width":663,"height":275,"caption":"itbusinesstoday"},"image":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15","name":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png90b3cb23d1d9c08733d969d29ea2d30d","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","caption":"ITBT StaffWriter"},"description":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc\u306f\u3001IT Business Today\u306e\u793e\u5185\u5bc4\u7a3f\u8005\u3067\u3001\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u30cb\u30e5\u30fc\u30b9\u3068QuickBytes\u306e\u914d\u4fe1\u3092\u62c5\u5f53\u3057\u3066\u3044\u307e\u3059\u3002IT\u3001\u30cf\u30a4\u30c6\u30af\u3001\u4f01\u696d\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u6700\u65b0\u52d5\u5411\u3092\u30ab\u30d0\u30fc\u3057\u3001\u7c21\u6f54\u3067\u30a4\u30f3\u30d1\u30af\u30c8\u306e\u3042\u308b\u6700\u65b0\u60c5\u5831\u3092\u8aad\u8005\u306b\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002","sameAs":["https:\/\/itbusinesstoday.com\/"],"url":"https:\/\/itbusinesstoday.com\/ja\/author\/itbt-staffwriter\/"}]}},"authors":[{"term_id":572,"user_id":7,"is_guest":0,"slug":"itbt-staffwriter","display_name":"ITBT StaffWriter","avatar_url":{"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","url2x":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png"},"author_category":"","first_name":"ITBT","last_name":"StaffWriter","user_url":"https:\/\/itbusinesstoday.com\/","job_title":"","description":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc\u306f\u3001IT Business Today\u306e\u793e\u5185\u5bc4\u7a3f\u8005\u3067\u3001\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u30cb\u30e5\u30fc\u30b9\u3068QuickBytes\u306e\u914d\u4fe1\u3092\u62c5\u5f53\u3057\u3066\u3044\u307e\u3059\u3002IT\u3001\u30cf\u30a4\u30c6\u30af\u3001\u4f01\u696d\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u6700\u65b0\u52d5\u5411\u3092\u30ab\u30d0\u30fc\u3057\u3001\u7c21\u6f54\u3067\u30a4\u30f3\u30d1\u30af\u30c8\u306e\u3042\u308b\u6700\u65b0\u60c5\u5831\u3092\u8aad\u8005\u306b\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002"}],"_links":{"self":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/18281","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/comments?post=18281"}],"version-history":[{"count":1,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/18281\/revisions"}],"predecessor-version":[{"id":18283,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/18281\/revisions\/18283"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media\/18282"}],"wp:attachment":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media?parent=18281"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/categories?post=18281"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/tags?post=18281"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/ppma_author?post=18281"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}